At the time of writing, Atea Pharmaceuticals Inc [AVIR] stock is trading at $4.12, up 12.88%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The AVIR shares have gain 19.77% over the last week, with a monthly amount glided 29.97%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Atea Pharmaceuticals Inc [NASDAQ: AVIR] stock has seen the most recent analyst activity on August 13, 2024, when Morgan Stanley upgraded its rating to a Equal-Weight and also boosted its price target to $6.88 from $2. Previously, JP Morgan downgraded its rating to Underweight on August 10, 2023. On January 06, 2022, downgrade downgraded it’s rating to Underweight and revised its price target to $7 on the stock. SVB Leerink downgraded its rating to a Mkt Perform. JP Morgan downgraded its rating to a Neutral and reduced its price target to $16 on October 20, 2021. Morgan Stanley downgraded its rating to Equal-Weight for this stock on October 05, 2021, but kept the price target unchanged to $55. In a note dated November 25, 2020, Evercore ISI initiated an Outperform rating.
For the past year, the stock price of Atea Pharmaceuticals Inc fluctuated between $2.45 and $4.02. Currently, Wall Street analysts expect the stock to reach $6.88 within the next 12 months. Atea Pharmaceuticals Inc [NASDAQ: AVIR] shares were valued at $4.12 at the most recent close of the market. An investor can expect a potential return of 66.99% based on the average AVIR price forecast.
Analyzing the AVIR fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.43, Equity is -0.38 and Total Capital is -0.51. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.0.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It is important to note that Atea Pharmaceuticals Inc [NASDAQ:AVIR] has a current ratio of 16.66. Also, the Quick Ratio is 16.66, while the Cash Ratio stands at 3.83.
